X4 Pharmaceuticals, Inc·4

Aug 22, 4:09 PM ET

WYZGA MICHAEL S 4

4 · X4 Pharmaceuticals, Inc · Filed Aug 22, 2023

Insider Transaction Report

Form 4
Period: 2023-08-18
Transactions
  • Purchase

    Common Stock

    2023-08-18$1.20/sh+25,000$29,87576,667 total
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in two transactions at $1.195 and $1.20. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price set forth in this footnote.
  • [F2]Of the shares of common stock reported, 48,333 shares represent restricted stock units.

Documents

1 file
  • 4
    wk-form4_1692734960.xmlPrimary

    FORM 4